3 Stocks Worth Keeping an Eye On: Medicinova (MNOV), Cardiol Therapeutics (CRDL), BeyondSpring (BYSI)
Clinical-stage biotechnology companies continue navigating a market shaped by research progress, investor engagement, and upcoming regulatory milestones. With healthcare innovation remaining a major focus for institutional and retail investors alike, companies demonstrating consistent development activity and expanding market visibility are attracting increased attention across the sector. Medicinova Inc (MNOV) Witnessing the stock’s movement on the … Read more